Health2Sync raised Series B funding for expansion into Japan raises Series B funding for market expansion to Japan. The diabetes management platform headquartered in Taiwan announced the latest US$6 million funding led by Japan's largest insurer Sompo Holdings Inc. to accelerate expansion into the international market in Japan.

Health2Sync otherwise known as H2 Inc. was founded by Ed Deng in 2013 to provide users with diabetes monitoring and analysis services. Previous investors include Alibaba Group and WI Harper Group. Startup says it will use the latest funds to speed up service to Japan.

Tinuku Health2Sync raised Series B funding for expansion into Japan

Deng said Japan is one of the largest markets in the world where nearly 10 million people suffer from diabetes-related diet and lifestyle issues. Health2Sync aims to provide an easy way to manage glucose levels through data-driven technology and easily identify issues that need attention.

It currently has more than 150,000 registered users across Taiwan, US, Japan, Hong Kong, Southeast Asia. Applications allow people to record blood sugar levels by synchronizing data measured from standard meters through an intuitive and user-friendly interface.

Health2Sync also provides a web-based patient management platform where doctors will continuously track every patient's health status and automatically analyze the data. The platform is also beneficial for insurance companies.

"The ability of Health2Sync to work with various stakeholders in ecosystems such as glucose meter manufacturing, pharmaceuticals and health insurance provides patients with new tools and approaches for true self-management," said Deputy General Manager of Sompo Digital Lab, Jun Fujita.